BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 664326 O=C(Cc1ccccc1)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C22H16N4O2/c27-22(12-15-6-2-1-3-7-15)24-20-10-11-21-23-14-17(26(21)25-20)19-13-16-8-4-5-9-18(16)28-19/h1-11,13-14H,12H2,(H,24,25,27) XDVBPXTUGFLXON-UHFFFAOYSA-N 337232 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-phenylacetamide::US9745304, Example 1 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 8.00 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337232 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337232&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77846996 384989287 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664327 OC(C(=O)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1)c1ccccc1 InChI=1S/C22H16N4O3/c27-21(14-6-2-1-3-7-14)22(28)24-19-10-11-20-23-13-16(26(20)25-19)18-12-15-8-4-5-9-17(15)29-18/h1-13,21,27H,(H,24,25,28) QXPFEBPNDCKVSY-UHFFFAOYSA-N 337233 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-hydroxy-2-phenylacetamide::US9745304, Example 2 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 7.00 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337233 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337233&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77846997 384989288 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664328 OC(C(=O)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1)c1cccnc1 InChI=1S/C21H15N5O3/c27-20(14-5-3-9-22-11-14)21(28)24-18-7-8-19-23-12-15(26(19)25-18)17-10-13-4-1-2-6-16(13)29-17/h1-12,20,27H,(H,24,25,28) FQFWDRRIGZELJC-UHFFFAOYSA-N 337234 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-hydroxy-2-(pyridin-3-yl)acetamide::US9745304, Example 3 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 3.00 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337234 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337234&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 76900001 384989289 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664329 OC(C1CCCCC1)C(=O)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C22H22N4O3/c27-21(14-6-2-1-3-7-14)22(28)24-19-10-11-20-23-13-16(26(20)25-19)18-12-15-8-4-5-9-17(15)29-18/h4-5,8-14,21,27H,1-3,6-7H2,(H,24,25,28) ICCQYTQJXWVGFI-UHFFFAOYSA-N 337235 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-cyclohexyl-2-hydroxyacetamide::US9745304, Example 4 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 7.00 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337235 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337235&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77846998 384989290 C03491 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664330 OC(C1CCOCC1)C(=O)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C21H20N4O4/c26-20(13-7-9-28-10-8-13)21(27)23-18-5-6-19-22-12-15(25(19)24-18)17-11-14-3-1-2-4-16(14)29-17/h1-6,11-13,20,26H,7-10H2,(H,23,24,27) PZYCUQOXELRUSR-UHFFFAOYSA-N 337236 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-hydroxy-2-(tetrahydro-2H-pyran-4-yl)acetamide::US9745304, Example 5 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 4.00 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337236 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337236&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77846999 384989291 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664331 O=C(Cc1ccccn1)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C21H15N5O2/c27-21(12-15-6-3-4-10-22-15)24-19-8-9-20-23-13-16(26(20)25-19)18-11-14-5-1-2-7-17(14)28-18/h1-11,13H,12H2,(H,24,25,27) HQFNIOFCBJTMAX-UHFFFAOYSA-N 337237 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-(pyridin-2-yl)acetamide::US9745304, Example 6 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 7.00 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337237 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337237&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847000 384989292 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664332 O=C(Cc1cccnc1)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C21H15N5O2/c27-21(10-14-4-3-9-22-12-14)24-19-7-8-20-23-13-16(26(20)25-19)18-11-15-5-1-2-6-17(15)28-18/h1-9,11-13H,10H2,(H,24,25,27) IBSWPCDMBCFSGG-UHFFFAOYSA-N 337238 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-(pyridin-3-yl)acetamide::US9745304, Example 7 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 5.00 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337238 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337238&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847001 384989293 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664333 Fc1cccc(CC(=O)Nc2ccc3ncc(-c4cc5ccccc5o4)n3n2)c1 InChI=1S/C22H15FN4O2/c23-16-6-3-4-14(10-16)11-22(28)25-20-8-9-21-24-13-17(27(21)26-20)19-12-15-5-1-2-7-18(15)29-19/h1-10,12-13H,11H2,(H,25,26,28) UJUIOOAUSDYSIL-UHFFFAOYSA-N 337239 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-(3-fluorophenyl)-acetamide::US9745304, Example 8 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 10.00 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337239 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337239&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847080 384989294 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664334 O=C(CCc1cccnc1)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C22H17N5O2/c28-22(10-7-15-4-3-11-23-13-15)25-20-8-9-21-24-14-17(27(21)26-20)19-12-16-5-1-2-6-18(16)29-19/h1-6,8-9,11-14H,7,10H2,(H,25,26,28) DIMYYEALYLMAGB-UHFFFAOYSA-N 337240 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-3-(pyridin-3-yl)propanamide::US9745304, Example 9 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 3.00 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337240 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337240&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847081 384989295 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664335 O=C(Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1)c1cc(=O)[nH]c(=O)[nH]1 InChI=1S/C19H12N6O4/c26-17-8-11(21-19(28)23-17)18(27)22-15-5-6-16-20-9-12(25(16)24-15)14-7-10-3-1-2-4-13(10)29-14/h1-9H,(H,22,24,27)(H2,21,23,26,28) PPWCXMBGMSTYLX-UHFFFAOYSA-N 337241 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxamide::US9745304, Example 10 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 36.0 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337241 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337241&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 138752871 384989296 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664336 OC[C@@H]1CCC(=O)N1c1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C19H16N4O3/c24-11-13-5-8-19(25)22(13)18-7-6-17-20-10-14(23(17)21-18)16-9-12-3-1-2-4-15(12)26-16/h1-4,6-7,9-10,13,24H,5,8,11H2/t13-/m0/s1 APAZAFAHWYCIQA-ZDUSSCGKSA-N 337242 (5S)-1-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-5-(hydroxymethyl)-pyrrolidin-2-one::US9745304, Example 11 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 3.00 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337242 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337242&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847083 384989297 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664337 OC(C1CC1)C(=O)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C19H16N4O3/c24-18(11-5-6-11)19(25)21-16-7-8-17-20-10-13(23(17)22-16)15-9-12-3-1-2-4-14(12)26-15/h1-4,7-11,18,24H,5-6H2,(H,21,22,25) PHSFIJKQTLJRMC-UHFFFAOYSA-N 337243 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-cyclopropyl-2-hydroxyacetamide::US9745304, Example 12 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 5.00 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337243 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337243&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847084 384989298 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664338 C[C@@H](O)C(=O)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C17H14N4O3/c1-10(22)17(23)19-15-6-7-16-18-9-12(21(16)20-15)14-8-11-4-2-3-5-13(11)24-14/h2-10,22H,1H3,(H,19,20,23)/t10-/m1/s1 ILOSUKCSYQKFFX-SNVBAGLBSA-N 337244 (2R)¿N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-hydroxypropanamide::US9745304, Example 13 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 4.00 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337244 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337244&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847085 384989299 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664339 C[C@H](O)C(=O)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C17H14N4O3/c1-10(22)17(23)19-15-6-7-16-18-9-12(21(16)20-15)14-8-11-4-2-3-5-13(11)24-14/h2-10,22H,1H3,(H,19,20,23)/t10-/m0/s1 ILOSUKCSYQKFFX-JTQLQIEISA-N 337245 (2S)¿N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-hydroxypropanamide::US9745304, Example 14 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 8.00 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337245 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337245&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847086 384989300 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664340 COc1nccc2oc(cc12)-c1cnc2ccc(NC(=O)[C@@H](C)O)nn12 InChI=1S/C17H15N5O4/c1-9(23)16(24)20-14-3-4-15-19-8-11(22(15)21-14)13-7-10-12(26-13)5-6-18-17(10)25-2/h3-9,23H,1-2H3,(H,20,21,24)/t9-/m1/s1 PJWUSWRCXKIDCP-SECBINFHSA-N 337246 (2R)-2-hydroxy-N-[3-(4-methoxyfuro[3,2-c]pyridin-2-yl)imidazo[1,2-b]-pyridazin-6-yl]propanamide::US9745304, Example 15 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 3.00 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337246 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337246&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847161 384989301 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664341 COc1nccc2oc(cc12)-c1cnc2ccc(NC(=O)[C@H](C)O)nn12 InChI=1S/C17H15N5O4/c1-9(23)16(24)20-14-3-4-15-19-8-11(22(15)21-14)13-7-10-12(26-13)5-6-18-17(10)25-2/h3-9,23H,1-2H3,(H,20,21,24)/t9-/m0/s1 PJWUSWRCXKIDCP-VIFPVBQESA-N 337247 (2S)-2-hydroxy-N-[3-(4-methoxyfuro[3,2-c]pyridin-2-yl)imidazo[1,2-b]pyridazin-6-yl]propanamide::US9745304, Example 16 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 10.00 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337247 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337247&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847162 384989302 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664342 CC(C)CC(=O)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C19H18N4O2/c1-12(2)9-19(24)21-17-7-8-18-20-11-14(23(18)22-17)16-10-13-5-3-4-6-15(13)25-16/h3-8,10-12H,9H2,1-2H3,(H,21,22,24) GUZOCJQPALBFDG-UHFFFAOYSA-N 337248 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-3-methylbutanamide::US9745304, Example 17 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 4.00 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337248 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337248&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847163 384989303 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664343 O=C(Cc1ccc(cc1)C#N)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C23H15N5O2/c24-13-16-7-5-15(6-8-16)11-23(29)26-21-9-10-22-25-14-18(28(22)27-21)20-12-17-3-1-2-4-19(17)30-20/h1-10,12,14H,11H2,(H,26,27,29) YKEPVEZYTGZSPT-UHFFFAOYSA-N 337249 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-(4-cyanophenyl)-acetamide::US9745304, Example 18 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 10.00 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337249 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337249&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847164 384989304 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664344 O=C(CCc1c[nH]cn1)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C20H16N6O2/c27-20(8-5-14-10-21-12-23-14)24-18-6-7-19-22-11-15(26(19)25-18)17-9-13-3-1-2-4-16(13)28-17/h1-4,6-7,9-12H,5,8H2,(H,21,23)(H,24,25,27) BCIIUYDUOQBHKE-UHFFFAOYSA-N 337250 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-3-(1H-imidazol-4-yl)-propanamide::US9745304, Example 19 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 8.00 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337250 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337250&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847165 384989305 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664345 Cn1cc(CCC(=O)Nc2ccc3ncc(-c4cc5ccccc5o4)n3n2)cn1 InChI=1S/C21H18N6O2/c1-26-13-14(11-23-26)6-9-21(28)24-19-7-8-20-22-12-16(27(20)25-19)18-10-15-4-2-3-5-17(15)29-18/h2-5,7-8,10-13H,6,9H2,1H3,(H,24,25,28) PAHSJNMOWPRPGR-UHFFFAOYSA-N 337251 N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6-yl]- 3-(1-methyl-1H-pyrazol-4- yl)propanamide::US9745304, Example 20 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 6.00 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337251 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337251&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 118599578 384989306 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664346 O=C(Cc1cccc(c1)C#N)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C23H15N5O2/c24-13-16-5-3-4-15(10-16)11-23(29)26-21-8-9-22-25-14-18(28(22)27-21)20-12-17-6-1-2-7-19(17)30-20/h1-10,12,14H,11H2,(H,26,27,29) VDNSWVFOVAECEA-UHFFFAOYSA-N 337252 N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6-yl]- 2-(3-cyanophenyl)acetamide::US9745304, Example 21 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 14.0 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337252 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337252&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847247 384989307 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664347 O=C(CCC1CC1)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C20H18N4O2/c25-20(10-7-13-5-6-13)22-18-8-9-19-21-12-15(24(19)23-18)17-11-14-3-1-2-4-16(14)26-17/h1-4,8-9,11-13H,5-7,10H2,(H,22,23,25) MCALTGVZBFASBT-UHFFFAOYSA-N 337253 N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6-yl]- 3-cyclopropylpropanamide::US9745304, Example 22 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 13.0 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337253 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337253&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847248 384989308 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664348 CCN(CC)CCC(=O)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C21H23N5O2/c1-3-25(4-2)12-11-21(27)23-19-9-10-20-22-14-16(26(20)24-19)18-13-15-7-5-6-8-17(15)28-18/h5-10,13-14H,3-4,11-12H2,1-2H3,(H,23,24,27) LJVYMGFVDGXMRC-UHFFFAOYSA-N 337254 N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6-yl]- N3,N3-diethyl-beta-alaninamide::US9745304, Example 23 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 9.00 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337254 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337254&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847249 384989309 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664349 O=C(Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1)C1(CC1)C#N InChI=1S/C19H13N5O2/c20-11-19(7-8-19)18(25)22-16-5-6-17-21-10-13(24(17)23-16)15-9-12-3-1-2-4-14(12)26-15/h1-6,9-10H,7-8H2,(H,22,23,25) SIRRALRYLSPTEY-UHFFFAOYSA-N 337255 N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6-yl]- 1-cyanocyclopropane carboxamide::US9745304, Example 24 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 25.0 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337255 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337255&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847250 384989310 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664350 FC(F)(F)c1ccccc1CC(=O)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C23H15F3N4O2/c24-23(25,26)16-7-3-1-5-14(16)12-22(31)28-20-9-10-21-27-13-17(30(21)29-20)19-11-15-6-2-4-8-18(15)32-19/h1-11,13H,12H2,(H,28,29,31) YZTIMMGUZXDJJP-UHFFFAOYSA-N 337256 N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6-yl]- 2-[2- (trifluoromethyl)phenyl]acetamide::US9745304, Example 25 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 31.0 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337256 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337256&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847251 384989311 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664351 O=C(CC#N)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C17H11N5O2/c18-8-7-17(23)20-15-5-6-16-19-10-12(22(16)21-15)14-9-11-3-1-2-4-13(11)24-14/h1-6,9-10H,7H2,(H,20,21,23) IVOLTHFUVJXAPG-UHFFFAOYSA-N 337257 N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6-yl]- 2-cyanoacetamide::US9745304, Example 26 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 14.0 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337257 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337257&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847252 384989312 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664352 O=C(Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1)C1CCOCC1 InChI=1S/C20H18N4O3/c25-20(13-7-9-26-10-8-13)22-18-5-6-19-21-12-15(24(19)23-18)17-11-14-3-1-2-4-16(14)27-17/h1-6,11-13H,7-10H2,(H,22,23,25) ZHKRRCTXZCUDKD-UHFFFAOYSA-N 337258 N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6- yl]tetrahydro-2H-pyran-4- carboxamide::US9745304, Example 27 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 25.0 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337258 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337258&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847330 384989313 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664353 CN(C)CC(=O)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C18H17N5O2/c1-22(2)11-18(24)20-16-7-8-17-19-10-13(23(17)21-16)15-9-12-5-3-4-6-14(12)25-15/h3-10H,11H2,1-2H3,(H,20,21,24) ZNCQPBAIESXLCS-UHFFFAOYSA-N 337259 N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6-yl]- N2,N2-dimethylglycinamide::US9745304, Example 28 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 17.0 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337259 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337259&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847331 384989314 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664354 Fc1ccc(CCC(=O)Nc2ccc3ncc(-c4cc5ccccc5o4)n3n2)cc1 InChI=1S/C23H17FN4O2/c24-17-8-5-15(6-9-17)7-12-23(29)26-21-10-11-22-25-14-18(28(22)27-21)20-13-16-3-1-2-4-19(16)30-20/h1-6,8-11,13-14H,7,12H2,(H,26,27,29) DVKRXTYEDGWONB-UHFFFAOYSA-N 337260 N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6-yl]- 3-(4-fluorophenyl)propanamide::US9745304, Example 29 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 44.0 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337260 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337260&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847332 384989315 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664355 O=C(CN1CCCC1)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C20H19N5O2/c26-20(13-24-9-3-4-10-24)22-18-7-8-19-21-12-15(25(19)23-18)17-11-14-5-1-2-6-16(14)27-17/h1-2,5-8,11-12H,3-4,9-10,13H2,(H,22,23,26) RFXGQIZWLZIASR-UHFFFAOYSA-N 337261 N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6-yl]- 2-(pyrrolidin-1-yl)acetamide::US9745304, Example 30 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 30.0 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337261 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337261&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847333 384989316 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664356 Cc1cccc(CCC(=O)Nc2ccc3ncc(-c4cc5ccccc5o4)n3n2)c1 InChI=1S/C24H20N4O2/c1-16-5-4-6-17(13-16)9-12-24(29)26-22-10-11-23-25-15-19(28(23)27-22)21-14-18-7-2-3-8-20(18)30-21/h2-8,10-11,13-15H,9,12H2,1H3,(H,26,27,29) KDJGBGJDYGZBCB-UHFFFAOYSA-N 337262 N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6-yl]- 3-(3-methylphenyl)propanamide::US9745304, Example 31 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 67.0 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337262 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337262&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847334 384989317 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 664357 CC1CCN(CC(=O)Nc2ccc3ncc(-c4cc5ccccc5o4)n3n2)CC1 InChI=1S/C22H23N5O2/c1-15-8-10-26(11-9-15)14-22(28)24-20-6-7-21-23-13-17(27(21)25-20)19-12-16-4-2-3-5-18(16)29-19/h2-7,12-13,15H,8-11,14H2,1H3,(H,24,25,28) QSNZOIMTTIUEHU-UHFFFAOYSA-N 337263 N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6-yl]- 2-(4-methylpiperidin-1- yl)acetamide::US9745304, Example 32 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 17.0 US Patent 10.7270/Q2D79DHV aid1797064 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337263 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337263&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847335 384989318 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665928 O=C(Cc1ccccc1)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C22H16N4O2/c27-22(12-15-6-2-1-3-7-15)24-20-10-11-21-23-14-17(26(21)25-20)19-13-16-8-4-5-9-18(16)28-19/h1-11,13-14H,12H2,(H,24,25,27) XDVBPXTUGFLXON-UHFFFAOYSA-N 337232 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-phenylacetamide::US9745304, Example 1 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 8.00 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337232 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337232&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77846996 384989287 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665929 OC(C(=O)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1)c1ccccc1 InChI=1S/C22H16N4O3/c27-21(14-6-2-1-3-7-14)22(28)24-19-10-11-20-23-13-16(26(20)25-19)18-12-15-8-4-5-9-17(15)29-18/h1-13,21,27H,(H,24,25,28) QXPFEBPNDCKVSY-UHFFFAOYSA-N 337233 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-hydroxy-2-phenylacetamide::US9745304, Example 2 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 7.00 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337233 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337233&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77846997 384989288 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665930 OC(C(=O)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1)c1cccnc1 InChI=1S/C21H15N5O3/c27-20(14-5-3-9-22-11-14)21(28)24-18-7-8-19-23-12-15(26(19)25-18)17-10-13-4-1-2-6-16(13)29-17/h1-12,20,27H,(H,24,25,28) FQFWDRRIGZELJC-UHFFFAOYSA-N 337234 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-hydroxy-2-(pyridin-3-yl)acetamide::US9745304, Example 3 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 3.00 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337234 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337234&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 76900001 384989289 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665931 OC(C1CCCCC1)C(=O)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C22H22N4O3/c27-21(14-6-2-1-3-7-14)22(28)24-19-10-11-20-23-13-16(26(20)25-19)18-12-15-8-4-5-9-17(15)29-18/h4-5,8-14,21,27H,1-3,6-7H2,(H,24,25,28) ICCQYTQJXWVGFI-UHFFFAOYSA-N 337235 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-cyclohexyl-2-hydroxyacetamide::US9745304, Example 4 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 7.00 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337235 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337235&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77846998 384989290 C03491 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665932 OC(C1CCOCC1)C(=O)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C21H20N4O4/c26-20(13-7-9-28-10-8-13)21(27)23-18-5-6-19-22-12-15(25(19)24-18)17-11-14-3-1-2-4-16(14)29-17/h1-6,11-13,20,26H,7-10H2,(H,23,24,27) PZYCUQOXELRUSR-UHFFFAOYSA-N 337236 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-hydroxy-2-(tetrahydro-2H-pyran-4-yl)acetamide::US9745304, Example 5 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 4.00 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337236 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337236&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77846999 384989291 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665933 O=C(Cc1ccccn1)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C21H15N5O2/c27-21(12-15-6-3-4-10-22-15)24-19-8-9-20-23-13-16(26(20)25-19)18-11-14-5-1-2-7-17(14)28-18/h1-11,13H,12H2,(H,24,25,27) HQFNIOFCBJTMAX-UHFFFAOYSA-N 337237 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-(pyridin-2-yl)acetamide::US9745304, Example 6 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 7.00 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337237 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337237&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847000 384989292 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665934 O=C(Cc1cccnc1)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C21H15N5O2/c27-21(10-14-4-3-9-22-12-14)24-19-7-8-20-23-13-16(26(20)25-19)18-11-15-5-1-2-6-17(15)28-18/h1-9,11-13H,10H2,(H,24,25,27) IBSWPCDMBCFSGG-UHFFFAOYSA-N 337238 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-(pyridin-3-yl)acetamide::US9745304, Example 7 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 5.00 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337238 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337238&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847001 384989293 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665935 Fc1cccc(CC(=O)Nc2ccc3ncc(-c4cc5ccccc5o4)n3n2)c1 InChI=1S/C22H15FN4O2/c23-16-6-3-4-14(10-16)11-22(28)25-20-8-9-21-24-13-17(27(21)26-20)19-12-15-5-1-2-7-18(15)29-19/h1-10,12-13H,11H2,(H,25,26,28) UJUIOOAUSDYSIL-UHFFFAOYSA-N 337239 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-(3-fluorophenyl)-acetamide::US9745304, Example 8 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 10.00 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337239 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337239&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847080 384989294 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665936 O=C(CCc1cccnc1)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C22H17N5O2/c28-22(10-7-15-4-3-11-23-13-15)25-20-8-9-21-24-14-17(27(21)26-20)19-12-16-5-1-2-6-18(16)29-19/h1-6,8-9,11-14H,7,10H2,(H,25,26,28) DIMYYEALYLMAGB-UHFFFAOYSA-N 337240 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-3-(pyridin-3-yl)propanamide::US9745304, Example 9 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 3.00 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337240 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337240&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847081 384989295 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665937 O=C(Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1)c1cc(=O)[nH]c(=O)[nH]1 InChI=1S/C19H12N6O4/c26-17-8-11(21-19(28)23-17)18(27)22-15-5-6-16-20-9-12(25(16)24-15)14-7-10-3-1-2-4-13(10)29-14/h1-9H,(H,22,24,27)(H2,21,23,26,28) PPWCXMBGMSTYLX-UHFFFAOYSA-N 337241 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxamide::US9745304, Example 10 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 36.0 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337241 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337241&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 138752871 384989296 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665938 OC[C@@H]1CCC(=O)N1c1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C19H16N4O3/c24-11-13-5-8-19(25)22(13)18-7-6-17-20-10-14(23(17)21-18)16-9-12-3-1-2-4-15(12)26-16/h1-4,6-7,9-10,13,24H,5,8,11H2/t13-/m0/s1 APAZAFAHWYCIQA-ZDUSSCGKSA-N 337242 (5S)-1-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-5-(hydroxymethyl)-pyrrolidin-2-one::US9745304, Example 11 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 3.00 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337242 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337242&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847083 384989297 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665939 OC(C1CC1)C(=O)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C19H16N4O3/c24-18(11-5-6-11)19(25)21-16-7-8-17-20-10-13(23(17)22-16)15-9-12-3-1-2-4-14(12)26-15/h1-4,7-11,18,24H,5-6H2,(H,21,22,25) PHSFIJKQTLJRMC-UHFFFAOYSA-N 337243 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-cyclopropyl-2-hydroxyacetamide::US9745304, Example 12 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 5.00 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337243 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337243&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847084 384989298 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665940 C[C@@H](O)C(=O)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C17H14N4O3/c1-10(22)17(23)19-15-6-7-16-18-9-12(21(16)20-15)14-8-11-4-2-3-5-13(11)24-14/h2-10,22H,1H3,(H,19,20,23)/t10-/m1/s1 ILOSUKCSYQKFFX-SNVBAGLBSA-N 337244 (2R)¿N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-hydroxypropanamide::US9745304, Example 13 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 4.00 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337244 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337244&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847085 384989299 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665941 C[C@H](O)C(=O)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C17H14N4O3/c1-10(22)17(23)19-15-6-7-16-18-9-12(21(16)20-15)14-8-11-4-2-3-5-13(11)24-14/h2-10,22H,1H3,(H,19,20,23)/t10-/m0/s1 ILOSUKCSYQKFFX-JTQLQIEISA-N 337245 (2S)¿N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-hydroxypropanamide::US9745304, Example 14 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 8.00 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337245 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337245&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847086 384989300 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665942 COc1nccc2oc(cc12)-c1cnc2ccc(NC(=O)[C@@H](C)O)nn12 InChI=1S/C17H15N5O4/c1-9(23)16(24)20-14-3-4-15-19-8-11(22(15)21-14)13-7-10-12(26-13)5-6-18-17(10)25-2/h3-9,23H,1-2H3,(H,20,21,24)/t9-/m1/s1 PJWUSWRCXKIDCP-SECBINFHSA-N 337246 (2R)-2-hydroxy-N-[3-(4-methoxyfuro[3,2-c]pyridin-2-yl)imidazo[1,2-b]-pyridazin-6-yl]propanamide::US9745304, Example 15 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 3.00 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337246 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337246&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847161 384989301 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665943 COc1nccc2oc(cc12)-c1cnc2ccc(NC(=O)[C@H](C)O)nn12 InChI=1S/C17H15N5O4/c1-9(23)16(24)20-14-3-4-15-19-8-11(22(15)21-14)13-7-10-12(26-13)5-6-18-17(10)25-2/h3-9,23H,1-2H3,(H,20,21,24)/t9-/m0/s1 PJWUSWRCXKIDCP-VIFPVBQESA-N 337247 (2S)-2-hydroxy-N-[3-(4-methoxyfuro[3,2-c]pyridin-2-yl)imidazo[1,2-b]pyridazin-6-yl]propanamide::US9745304, Example 16 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 10.00 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337247 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337247&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847162 384989302 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665944 CC(C)CC(=O)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C19H18N4O2/c1-12(2)9-19(24)21-17-7-8-18-20-11-14(23(18)22-17)16-10-13-5-3-4-6-15(13)25-16/h3-8,10-12H,9H2,1-2H3,(H,21,22,24) GUZOCJQPALBFDG-UHFFFAOYSA-N 337248 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-3-methylbutanamide::US9745304, Example 17 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 4.00 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337248 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337248&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847163 384989303 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665945 O=C(Cc1ccc(cc1)C#N)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C23H15N5O2/c24-13-16-7-5-15(6-8-16)11-23(29)26-21-9-10-22-25-14-18(28(22)27-21)20-12-17-3-1-2-4-19(17)30-20/h1-10,12,14H,11H2,(H,26,27,29) YKEPVEZYTGZSPT-UHFFFAOYSA-N 337249 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-2-(4-cyanophenyl)-acetamide::US9745304, Example 18 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 10.00 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337249 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337249&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847164 384989304 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665946 O=C(CCc1c[nH]cn1)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C20H16N6O2/c27-20(8-5-14-10-21-12-23-14)24-18-6-7-19-22-11-15(26(19)25-18)17-9-13-3-1-2-4-16(13)28-17/h1-4,6-7,9-12H,5,8H2,(H,21,23)(H,24,25,27) BCIIUYDUOQBHKE-UHFFFAOYSA-N 337250 N-[3-(1-Benzofuran-2-yl)imidazo[1,2-b]pyridazin-6-yl]-3-(1H-imidazol-4-yl)-propanamide::US9745304, Example 19 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 8.00 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337250 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337250&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847165 384989305 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665947 Cn1cc(CCC(=O)Nc2ccc3ncc(-c4cc5ccccc5o4)n3n2)cn1 InChI=1S/C21H18N6O2/c1-26-13-14(11-23-26)6-9-21(28)24-19-7-8-20-22-12-16(27(20)25-19)18-10-15-4-2-3-5-17(15)29-18/h2-5,7-8,10-13H,6,9H2,1H3,(H,24,25,28) PAHSJNMOWPRPGR-UHFFFAOYSA-N 337251 N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6-yl]- 3-(1-methyl-1H-pyrazol-4- yl)propanamide::US9745304, Example 20 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 6.00 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337251 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337251&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 118599578 384989306 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665948 O=C(Cc1cccc(c1)C#N)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C23H15N5O2/c24-13-16-5-3-4-15(10-16)11-23(29)26-21-8-9-22-25-14-18(28(22)27-21)20-12-17-6-1-2-7-19(17)30-20/h1-10,12,14H,11H2,(H,26,27,29) VDNSWVFOVAECEA-UHFFFAOYSA-N 337252 N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6-yl]- 2-(3-cyanophenyl)acetamide::US9745304, Example 21 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 14.0 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337252 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337252&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847247 384989307 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665949 O=C(CCC1CC1)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C20H18N4O2/c25-20(10-7-13-5-6-13)22-18-8-9-19-21-12-15(24(19)23-18)17-11-14-3-1-2-4-16(14)26-17/h1-4,8-9,11-13H,5-7,10H2,(H,22,23,25) MCALTGVZBFASBT-UHFFFAOYSA-N 337253 N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6-yl]- 3-cyclopropylpropanamide::US9745304, Example 22 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 13.0 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337253 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337253&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847248 384989308 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665950 CCN(CC)CCC(=O)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C21H23N5O2/c1-3-25(4-2)12-11-21(27)23-19-9-10-20-22-14-16(26(20)24-19)18-13-15-7-5-6-8-17(15)28-18/h5-10,13-14H,3-4,11-12H2,1-2H3,(H,23,24,27) LJVYMGFVDGXMRC-UHFFFAOYSA-N 337254 N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6-yl]- N3,N3-diethyl-beta-alaninamide::US9745304, Example 23 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 9.00 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337254 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337254&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847249 384989309 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665951 O=C(Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1)C1(CC1)C#N InChI=1S/C19H13N5O2/c20-11-19(7-8-19)18(25)22-16-5-6-17-21-10-13(24(17)23-16)15-9-12-3-1-2-4-14(12)26-15/h1-6,9-10H,7-8H2,(H,22,23,25) SIRRALRYLSPTEY-UHFFFAOYSA-N 337255 N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6-yl]- 1-cyanocyclopropane carboxamide::US9745304, Example 24 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 25.0 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337255 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337255&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847250 384989310 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665952 FC(F)(F)c1ccccc1CC(=O)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C23H15F3N4O2/c24-23(25,26)16-7-3-1-5-14(16)12-22(31)28-20-9-10-21-27-13-17(30(21)29-20)19-11-15-6-2-4-8-18(15)32-19/h1-11,13H,12H2,(H,28,29,31) YZTIMMGUZXDJJP-UHFFFAOYSA-N 337256 N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6-yl]- 2-[2- (trifluoromethyl)phenyl]acetamide::US9745304, Example 25 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 31.0 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337256 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337256&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847251 384989311 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665953 O=C(CC#N)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C17H11N5O2/c18-8-7-17(23)20-15-5-6-16-19-10-12(22(16)21-15)14-9-11-3-1-2-4-13(11)24-14/h1-6,9-10H,7H2,(H,20,21,23) IVOLTHFUVJXAPG-UHFFFAOYSA-N 337257 N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6-yl]- 2-cyanoacetamide::US9745304, Example 26 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 14.0 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337257 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337257&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847252 384989312 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665954 O=C(Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1)C1CCOCC1 InChI=1S/C20H18N4O3/c25-20(13-7-9-26-10-8-13)22-18-5-6-19-21-12-15(24(19)23-18)17-11-14-3-1-2-4-16(14)27-17/h1-6,11-13H,7-10H2,(H,22,23,25) ZHKRRCTXZCUDKD-UHFFFAOYSA-N 337258 N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6- yl]tetrahydro-2H-pyran-4- carboxamide::US9745304, Example 27 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 25.0 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337258 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337258&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847330 384989313 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665955 CN(C)CC(=O)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C18H17N5O2/c1-22(2)11-18(24)20-16-7-8-17-19-10-13(23(17)21-16)15-9-12-5-3-4-6-14(12)25-15/h3-10H,11H2,1-2H3,(H,20,21,24) ZNCQPBAIESXLCS-UHFFFAOYSA-N 337259 N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6-yl]- N2,N2-dimethylglycinamide::US9745304, Example 28 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 17.0 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337259 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337259&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847331 384989314 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665956 Fc1ccc(CCC(=O)Nc2ccc3ncc(-c4cc5ccccc5o4)n3n2)cc1 InChI=1S/C23H17FN4O2/c24-17-8-5-15(6-9-17)7-12-23(29)26-21-10-11-22-25-14-18(28(22)27-21)20-13-16-3-1-2-4-19(16)30-20/h1-6,8-11,13-14H,7,12H2,(H,26,27,29) DVKRXTYEDGWONB-UHFFFAOYSA-N 337260 N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6-yl]- 3-(4-fluorophenyl)propanamide::US9745304, Example 29 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 44.0 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337260 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337260&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847332 384989315 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665957 O=C(CN1CCCC1)Nc1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C20H19N5O2/c26-20(13-24-9-3-4-10-24)22-18-7-8-19-21-12-15(25(19)23-18)17-11-14-5-1-2-6-16(14)27-17/h1-2,5-8,11-12H,3-4,9-10,13H2,(H,22,23,26) RFXGQIZWLZIASR-UHFFFAOYSA-N 337261 N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6-yl]- 2-(pyrrolidin-1-yl)acetamide::US9745304, Example 30 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 30.0 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337261 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337261&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847333 384989316 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665958 Cc1cccc(CCC(=O)Nc2ccc3ncc(-c4cc5ccccc5o4)n3n2)c1 InChI=1S/C24H20N4O2/c1-16-5-4-6-17(13-16)9-12-24(29)26-22-10-11-23-25-15-19(28(23)27-22)21-14-18-7-2-3-8-20(18)30-21/h2-8,10-11,13-15H,9,12H2,1H3,(H,26,27,29) KDJGBGJDYGZBCB-UHFFFAOYSA-N 337262 N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6-yl]- 3-(3-methylphenyl)propanamide::US9745304, Example 31 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 67.0 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337262 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337262&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847334 384989317 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 665959 CC1CCN(CC(=O)Nc2ccc3ncc(-c4cc5ccccc5o4)n3n2)CC1 InChI=1S/C22H23N5O2/c1-15-8-10-26(11-9-15)14-22(28)24-20-6-7-21-23-13-17(27(21)25-20)19-12-16-4-2-3-5-18(16)29-19/h2-7,12-13,15H,8-11,14H2,1H3,(H,24,25,28) QSNZOIMTTIUEHU-UHFFFAOYSA-N 337263 N-[3-(1-benzofuran-2- yl)imidazo[1,2-b]pyridazin-6-yl]- 2-(4-methylpiperidin-1- yl)acetamide::US9745304, Example 32 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 17.0 US Patent 10.7270/Q2D79DHV aid1797065 US9745304 Zorn, L; Eis, K; Schulze, V; Sulzle, D; Puehler, F; Lienau, P; Bomer, U; Petersen, K; Hagebarth, A 8/29/2017 7/5/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=337263 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=337263&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 77847335 384989318 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6